Search - tctmd.com

Displaying 121 - 140 of 552

Sort: Relevancy | Date

News Conference News TCT 2022

Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4

Yael L. Maxwell

September 23, 2022

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

News Conference News TCT 2022

Valve Fracture for ViV TAVI Linked With Higher Mortality

Michael O'Riordan

September 22, 2022

News Conference News TCT 2022

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Todd Neale

September 22, 2022

News Conference News TCT 2022

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

Yael L. Maxwell

September 21, 2022

News Conference News TCT 2022

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

Todd Neale

September 21, 2022

Presentation TCT 2022

Con

Presenter: Nihar Desai

September 19, 2022

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

Presenter: Pablo Salinas

September 19, 2022

Presentation TCT 2022

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Presenter: Jonas Haener

September 19, 2022

Presentation TCT 2022

TCT 165: A Novel Ticagrelor Coated Stent to Eliminate the Need for Anti Platelet Therapy Post PCI

Presenter: Jared Romeo

September 19, 2022

Presentation TCT 2022

Cutting Balloon to Optimize Predilatation for Stent Implantation: The COPS Randomized Trial

Presenter: Antonio Mangieri

September 19, 2022

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

Presentation TCT 2022

Cardiogenic Shock Trials: Defining the Clinical Need and Framing the Issues

Presenter: Navin Kapur

September 19, 2022

News Conference News TCT 2022

Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning

Shelley Wood

September 19, 2022

Presentation TCT 2022

TCT 33: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Chronic Kidney Diabetes: Results From the PTRG-DES Registry

Presenter: Sang Yeub Lee

September 19, 2022

Presentation TCT 2022

TCT 32: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients According to LV Dysfunction Status: Analysis from PTRG-DES(Platelet function and genoType-Related long-term proGnosis in DES-treated patients)…

Presenter: Donghoon Han

September 19, 2022

Presentation TCT 2022

TCT 31: Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent

Presenter: Seung Hun Lee

September 19, 2022

Presentation TCT 2022

TCT 30: Platelet Reactivity and Clinical Outcomes after Drug-Eluting Stent Implantation in East Asian Patients: Results from the PTRG-DES Consortium

Presenter: Byeong-Keuk Kim

September 19, 2022

Advertisement

Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4

Most Patient-Reported Outcome Measures in CVD Fall Short

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Valve Fracture for ViV TAVI Linked With Higher Mortality

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

Con

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

TCT 165: A Novel Ticagrelor Coated Stent to Eliminate the Need for Anti Platelet Therapy Post PCI

Cutting Balloon to Optimize Predilatation for Stent Implantation: The COPS Randomized Trial

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Cardiogenic Shock Trials: Defining the Clinical Need and Framing the Issues

Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning

TCT 33: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Chronic Kidney Diabetes: Results From the PTRG-DES Registry

TCT 32: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients According to LV Dysfunction Status: Analysis from PTRG-DES(Platelet function and genoType-Related long-term proGnosis in DES-treated patients)…

TCT 31: Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent

TCT 30: Platelet Reactivity and Clinical Outcomes after Drug-Eluting Stent Implantation in East Asian Patients: Results from the PTRG-DES Consortium

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content